|
Crux gets FDA nod for inferior vena cava filter
 July 19, 2012 -- Crux Biomedical has received U.S. Food and Drug Administration (FDA) clearance for its inferior vena cava filter with bidirectional retrieval.
To view the remainder of this article, and other exclusive content, you must first sign-in or register using the options below.
(Helptag:PaywallArticleLoginMessage)
| |
|
|
New AuntMinnie.com Members
|
Becoming a Member is FREE!
|
Real-time radiology-specific news
Case of the Day and Teaching Files
Focused topics digital communities
Lively, discussion groups
Medical imaging bookstore
SalaryScan
Job Boards
OnLine CMe/CE
Bookstore, market reports, more …
Conference Calendar
User-controlled eNewsletters
… registration is FREE and easy!
|
| |
|
The Crux VCF is designed to facilitate bidirectional retrieval through either the femoral or jugular veins, according to the company. In a recently completed trial presented at the 2012 Society for Interventional Radiology (SIR) meeting, researchers found a 98% success rate for both filter deployment and retrieval in 125 patients from 22 sites in the U.S., Australia, New Zealand, and Belgium.
No embolizations, migrations, or fractures were observed at six-month follow-up, Crux said. | |
|